Your browser doesn't support javascript.
loading
Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.
Shelley, L E A; Scaife, J E; Romanchikova, M; Harrison, K; Forman, J R; Bates, A M; Noble, D J; Jena, R; Parker, M A; Sutcliffe, M P F; Thomas, S J; Burnet, N G.
Afiliação
  • Shelley LEA; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Medical Physics and Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, United Kingdom; Department of Engineering, University of Cambridge, United Kingdom. Electronic add
  • Scaife JE; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Oncology, University of Cambridge, United Kingdom.
  • Romanchikova M; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Medical Physics and Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, United Kingdom.
  • Harrison K; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Cavendish Laboratory, University of Cambridge, United Kingdom.
  • Forman JR; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, United Kingdom.
  • Bates AM; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Oncology, University of Cambridge, United Kingdom.
  • Noble DJ; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Oncology, University of Cambridge, United Kingdom.
  • Jena R; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Oncology, University of Cambridge, United Kingdom.
  • Parker MA; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Cavendish Laboratory, University of Cambridge, United Kingdom.
  • Sutcliffe MPF; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Engineering, University of Cambridge, United Kingdom.
  • Thomas SJ; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Medical Physics and Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, United Kingdom.
  • Burnet NG; Cambridge University Hospitals NHS Foundation Trust, Department of Oncology, United Kingdom; Department of Oncology, University of Cambridge, United Kingdom.
Radiother Oncol ; 123(3): 466-471, 2017 06.
Article em En | MEDLINE | ID: mdl-28460825
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Reto / Planejamento da Radioterapia Assistida por Computador Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2017 Tipo de documento: Article País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Reto / Planejamento da Radioterapia Assistida por Computador Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Radiother Oncol Ano de publicação: 2017 Tipo de documento: Article País de publicação: Irlanda